SK-Hep-1 (人肝窦内皮细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma(2022/11/15)

  作者：Hu, Qingqing, Liu, Qiuhong, Zhao, Yalei, Zhang, Lingjian, Li, Lanjuan

  期刊：Biomarker Research

  DOI：10.1186/s40364-022-00422-z

  影响因子 ：11.100

  引用产品：CL-0102 CL-0212

• Neuropilin-1 aggravates liver cirrhosis by promoting angiogenesis via VEGFR2-dependent PI3K/Akt pathway in hepatic sinusoidal endothelial cells(2019/05/03)

  作者：Le Wang, Yuemin Feng, Xiaoyu Xie

  期刊：EBioMedicine

  DOI：10.1016/j.ebiom.2019.04.050

  影响因子 ：11.100

  引用产品：CL-0212

• Nanoparticle-Stabilized Emulsion Bioink for Digital Light Processing Based 3D Bioprinting of Porous Tissue Constructs(2022/03/04)

  作者：Jie Tao, Shunyao Zhu, Nazi Zhou

  期刊：Advanced Healthcare Materials

  DOI：10.1002/adhm.202102810

  影响因子 ：11.092

  引用产品：CL-0044 CL-0171 CL-0212

• ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression(2022/08/01)

  作者：Yu You, Diguang Wen, Lu Zeng

  期刊：International Journal of Biological Sciences

  DOI：10.7150/ijbs.70149

  影响因子 ：9.200

  引用产品：CL-0102 CL-0103 CL-0120 CL-0212 CL-0233 CL-0341

• ncRNAs-mediated high expression of TICRR promotes tumor cell proliferation and migration and is correlated with poor prognosis and tumor immune infiltration of hepatocellular carcinoma(2022/09/19)

  作者：Kejie He, Yangfan Zhang, Laiying Liang

  期刊：Molecular Therapy-Nucleic Acids

  DOI：10.1016/j.omtn.2022.09.007

  影响因子 ：8.800

  引用产品：CL-0120 CL-0212

• S-palmitoylation of PCSK9 induces sorafenib resistance in liver cancer by activating the PI3K/AKT pathway(2022/08/16)

  作者：Yan Sun, Huan Zhang, Junpeng Meng

  期刊：Cell Reports

  DOI：10.1016/j.celrep.2022.111194

  影响因子 ：8.800

  引用产品：CL-0005 CL-0102 CL-0103 CL-0120 CL-0212

• Comprehensive analysis of ubiquitin‐specific protease 1 reveals its importance in hepatocellular carcinoma(2020/09/19)

  作者：Yalei Zhao, Chen Xue, Zhongyang Xie

  期刊：Cell Proliferation

  DOI：10.1111/cpr.12908

  影响因子 ：8.500

  引用产品：CL-0212

• LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway(2021/11/27)

  作者：Ying Xing,Yang Liu，Zhong Qi

  期刊：Cellular & Molecular Biology Letters

  DOI：10.1186/s11658-021-00295-4

  影响因子 ：8.300

  引用产品：CL-0102 CL-0120 CL-0212

• 5′-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with eukaryotic initiation factor 4A-I(2023/03/28)

  作者：Chengdong Wu, Dekai Liu, Lufei Zhang

  期刊：Frontiers of Medicine

  DOI：10.1007/s11684-022-0966-6

  影响因子 ：8.100

  引用产品：CL-0102 CL-0120 CL-0139 CL-0212

• BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma(2024/02/10)

  作者：Zongdong Yu, Xiang Wu, Jie Zhu

  期刊：CELLULAR AND MOLECULAR LIFE SCIENCES

  DOI：10.1007/s00018-024-05144-z

  影响因子 ：8.000

  引用产品：CL-0212

• Identification and analysis of C17orf53 as a prognostic signature for hepatocellular carcinoma(2022/11/28)

  作者：Yalei Zhao, Lingjian Zhang, Qingqing Hu, Danhua Zhu, Zhongyang Xie

  期刊：COMPUTERS IN BIOLOGY AND MEDICINE

  DOI：10.1016/j.compbiomed.2022.106348

  影响因子 ：7.700

  引用产品：CL-0212

• Constructing a disulfidptosis-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing and weighted co-expression network analysis(2024/05/17)

  作者：Zelin Tian, Junbo Song, Jiang She

  期刊：APOPTOSIS

  DOI：10.1007/s10495-024-01968-z

  影响因子 ：7.200

  引用产品：CL-0212

• Dual role of PID1 in regulating apoptosis induced by distinct anticancer-agents through AKT/Raf-1-dependent pathway in hepatocellular carcinoma(2023/04/28)

  作者：Jian Yang, Senlin Li, Jialuo He

  期刊：Cell Death Discovery

  DOI：10.1038/s41420-023-01405-1

  影响因子 ：7.000

  引用产品：CL-0102 CL-0103 CL-0212

• Transfer RNA‐derived fragment 5′tRF‐Gly promotes the development of hepatocellular carcinoma by direct targeting of carcinoembryonic antigen‐related cell adhesion molecule 1(2022/08/16)

  作者：Dekai Liu, Chengdong Wu, Jingjie Wang

  期刊：CANCER SCIENCE

  DOI：10.1111/cas.15505

  影响因子 ：6.518

  引用产品：CL-0212

• VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4(2022/10/14)

  作者：Xiaobao Shi, Pengfei Zhao, Gang Zhao

  期刊：Cancer Gene Therapy

  DOI：10.1038/s41417-022-00540-8

  影响因子 ：6.400

  引用产品：CL-0102 CL-0120 CL-0212 CL-0415

• A triggered DNA nanomachine with enzyme-free for the rapid detection of telomerase activity in a one-step method(2024/02/27)

  作者：Huajie Pang, Yanan Peng, Rui Zhang

  期刊：ANALYTICA CHIMICA ACTA

  DOI：10.1016/j.aca.2024.342420

  影响因子 ：6.200

  引用产品：CL-0212

• Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding(2021/10/19)

  作者：Rao Fu, Fangjing Yu, Weiqi Wu

  期刊：International Immunopharmacology

  DOI：10.1016/j.intimp.2021.108195

  影响因子 ：5.714

  引用产品：CL-0103 CL-0212 CL-0533 CM-0533

• TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway(2024/03/12)

  作者：Bo Shu, Yingxia Zhou, Guoqiong Lei

  期刊：CANCER SCIENCE

  DOI：10.1111/cas.16134

  影响因子 ：5.700

  引用产品：CL-0212

• Celecoxib reduces hepatic vascular resistance in portal hypertension by amelioration of endothelial oxidative stress(2021/10/05)

  作者：Yang Tai, Chong Zhao, Linhao Zhang

  期刊：Journal Of Cellular And Molecular Medicine

  DOI：10.1111/jcmm.16968

  影响因子 ：5.300

  引用产品：CL-0212

• PI3K δ inhibitor PI-3065 induces apoptosis in hepatocellular carcinoma cells by targeting survivin(2023/01/06)

  作者：Yuze Wei, Weiwei Ke, Zaiming Lu

  期刊：CHEMICO-BIOLOGICAL INTERACTIONS

  DOI：10.1016/j.cbi.2023.110343

  影响因子 ：5.100

  引用产品：CL-0103 CL-0212

• Daphnetin inhibits the survival of hepatocellular carcinoma cells through regulating Wnt/β-catenin signaling pathway(2022/02/07)

  作者：Chaohui Liu, Jiansheng Pan, Hongyu Liu

  期刊：Drug Development Research

  DOI：10.1002/ddr.21920

  影响因子 ：5.004

  引用产品：CL-0120 CL-0212

• Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response(2022/08/01)

  作者：Ipargul Hafiz, Zhezhe Li, Zhaozhi Wang

  期刊：JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

  DOI：10.1016/j.jddst.2022.103623

  影响因子 ：5.000

  引用产品：CL-0212

• Pan-cancer analysis of 60S Ribosomal Protein L7-Like 1 (RPL7L1) and validation in liver hepatocellular carcinoma(2023/12/01)

  作者：Kejie He, Guoyu Gong, E Liang

  期刊：Translational Oncology

  DOI：10.1016/j.tranon.2023.101844

  影响因子 ：5.000

  引用产品：CL-0212

• Multimodal Theranostic Nanoparticles for Necrosis Targeting, Fluorescence/SPECT Imaging, and Radiotherapy of Residual Tumors after Hepatocellular Carcinoma Ablation(2024/03/07)

  作者：Han Bao, Ning Wang, Song Chen

  期刊：MOLECULAR PHARMACEUTICS

  DOI：10.1021/acs.molpharmaceut.3c01081

  影响因子 ：4.900

  引用产品：CL-0212

• The P53-P21-RB1 pathway promotes BRD4 degradation in liver cancer through USP1(2024/02/01)

  作者：Neng Li, Erlei Zhang, Zhenyong Li

  期刊：JOURNAL OF BIOLOGICAL CHEMISTRY

  DOI：10.1016/j.jbc.2024.105707

  影响因子 ：4.800

  引用产品：CL-0212

• Tumor purity–associated genes influence hepatocellular carcinoma prognosis and tumor microenvironment(2023/06/26)

  作者：Yan Zhao, Xu Xu, Yue Wang

  期刊：Frontiers in Oncology

  DOI：10.3389/fonc.2023.1197898

  影响因子 ：4.700

  引用产品：CL-0103 CL-0212 CL-0560 CL-0811

• System analysis based on the lysosome-related genes identifies HPS4 as a novel therapy target for liver hepatocellular carcinoma(2023/09/13)

  作者：Kejie He, Zhiqiang Nie

  期刊：Frontiers in Oncology

  DOI：10.3389/fonc.2023.1221498

  影响因子 ：4.700

  引用产品：CL-0120 CL-0212

• Circ_0007429/miR-637/TRIM71/Ago2 axis participates in the regulation of proliferation, migration, invasion, apoptosis, and aerobic glycolysis of HCC(2023/03/15)

  作者：Lilan Fan, Panpan Xia, Jing Wang

  期刊：MOLECULAR CARCINOGENESIS

  DOI：10.1002/mc.23526

  影响因子 ：4.600

  引用产品：CL-0102 CL-0103 CL-0120 CL-0212

• Humanized disulfide-stabilized diabody against fibroblast growth factor-2 inhibits PD-L1 expression and epithelial-mesenchymal transition in hepatoma cells through STAT3(2023/07/25)

  作者：Huamin Sun, Xinran Song, Cunjie Li

  期刊：IUBMB LIFE

  DOI：10.1002/iub.2766

  影响因子 ：4.600

  引用产品：CL-0103 CL-0212

• Antipsychotic agent pimozide promotes reversible proliferative suppression by inducing cellular quiescence in liver cancer(2019/07/11)

  作者：Jiajie Chen, Lina Zhang, Nan Cai

  期刊：Oncology Reports

  DOI：10.3892/or.2019.7229

  影响因子 ：4.200

  引用产品：CL-0212

• miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2(2024/02/23)

  作者：Mingzhi Xia, Jie Chen, Yingyun Hu

  期刊：CANCER BIOLOGY & THERAPY

  DOI：10.1080/15384047.2024.2315651

  影响因子 ：3.600

  引用产品：CL-0212

• PAQR4 promotes the development of hepatocellular carcinoma by activating PI3K/AKT pathway(2021/10/30)

  作者：Gang Zhao, Xiaobao Shi, Zhanbo Sun

  期刊：Acta Biochimica Et Biophysica Sinica

  DOI：10.1093/abbs/gmab143

  影响因子 ：3.511

  引用产品：CL-0120 CL-0212 CL-0415

• Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis(2020/03/12)

  作者：Huaqiang Bi, Zhonghui Li, Hui Zhang

  期刊：Hepatobiliary & Pancreatic Diseases International

  DOI：10.1016/j.hbpd.2020.02.011.

  影响因子 ：3.300

  引用产品：CL-0119 CL-0120 CL-0212

• Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma(2022/01/25)

  作者：Xu Qian, Zhongming Bao, Dan Yao

  期刊：Kaohsiung Journal of Medical Sciences

  DOI：10.1002/kjm2.12501

  影响因子 ：3.300

  引用产品：164210 164210-50 CL-0120 CL-0212 PB180120

• Identify GADD45G as a potential target of 4-methoxydalbergione in treatment of liver cancer: bioinformatics analysis and in vivo experiment(2023/10/13)

  作者：Liping Zeng, Yuqi Qin, Xiaomin Lu

  期刊：World Journal of Surgical Oncology

  DOI：10.1186/s12957-023-03214-3

  影响因子 ：3.200

  引用产品：CL-0212

• ZNF131 facilitates the growth of hepatocellular carcinoma by acting as a transcriptional activator of SMC4 expression(2024/01/11)

  作者：Meng Jin, Yang Mi, Fazhan Li

  期刊：BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

  DOI：10.1016/j.bbrc.2024.149515

  影响因子 ：3.100

  引用产品：CL-0212

• NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma(2023/01/21)

  作者：Zigang Li, Chengshan You, Jun Huang

  期刊：MEDICAL SCIENCE MONITOR

  DOI：10.12659/MSM.938410

  影响因子 ：3.100

  引用产品：CL-0102 CL-0212

• Prognostic and Immune Infiltration Analysis of Transaldolase 1 (TALDO1) in Hepatocellular Carcinoma(2023/12/31)

  作者：Kedan Cen, Caide Lu

  期刊：International Journal of General Medicine

  DOI：10.2147/IJGM.S425490

  影响因子 ：2.300

  引用产品：CL-0212

• Long non-coding RNA AK058003, as a precursor of miR-15a, interacts with HuR to inhibit the expression of Υ-synuclein in hepatocellular carcinoma cells(2016/12/27)

  作者：Xiaoqin He, Yongfa Zheng, Yuefeng Zhang

  期刊：Oncotarget

  DOI：10.18632/oncotarget.14276

  影响因子 ：0.000

  引用产品：CL-0103 CL-0212

点击展开收起列表